Loading clinical trials...
Loading clinical trials...
Artidis Nanomechanical Signature Profiling of Pancreatic Cancer Specimens (ANoPs)
Conditions
Interventions
ARTIDIS ART-1 Device
Locations
1
United States
Moffitt Cancer Center
Tampa, Florida, United States
Start Date
April 1, 2026
Primary Completion Date
May 1, 2028
Completion Date
May 1, 2030
Last Updated
April 21, 2026
NCT07283705
NCT07438106
NCT05053971
NCT03937453
NCT06001268
NCT04550494
Lead Sponsor
ARTIDIS AG
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions